Literature DB >> 10397403

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.

D F Horrobin1, C N Bennett.   

Abstract

Depression and bipolar disorder are two of the commonest illnesses in the developed world. While some patients can be treated effectively with available drugs, many do not respond, especially in the depression related to bipolar disorder. Depression is associated with diabetes, cardiovascular disease, immunological abnormalities, multiple sclerosis, cancer, osteoporosis and ageing: in each case depressed individuals have a worse outcome than non-depressed individuals. In all of these conditions there is now evidence of impaired phospholipid metabolism and impaired fatty acid-related signal transduction processes. Impaired fatty acid and phospholipid metabolism may be a primary cause of depression in many patients and may explain the interactions with other diseases. Several novel gene candidates for involvement in depression and bipolar disorder are proposed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397403     DOI: 10.1054/plef.1999.0037

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  47 in total

1.  Dietary fat intake and the brain: a developing frontier in biological psychiatry.

Authors:  C E Greenwood; S N Young
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Depression and coronary artery disease: time to move from observation to trials.

Authors:  François Lespérance; Nancy Frasure-Smith
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

Review 3.  Osteoporosis and depression: a historical perspective.

Authors:  Deborah T Gold; Samantha Solimeo
Journal:  Curr Osteoporos Rep       Date:  2006-12       Impact factor: 5.096

4.  Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study.

Authors:  A J Søgaard; R M Joakimsen; A Tverdal; V Fønnebø; J H Magnus; G K R Berntsen
Journal:  Osteoporos Int       Date:  2004-12-24       Impact factor: 4.507

5.  Omega-3 fatty acids and multiple sclerosis: relationship to depression.

Authors:  Robin L Aupperle; Douglas R Denney; Sharon G Lynch; Susan E Carlson; Debra K Sullivan
Journal:  J Behav Med       Date:  2008-04

Review 6.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

7.  Skin aging and photoaging alter fatty acids composition, including 11,14,17-eicosatrienoic acid, in the epidermis of human skin.

Authors:  Eun Ju Kim; Min-Kyoung Kim; Xing-Ji Jin; Jang-Hee Oh; Ji Eun Kim; Jin Ho Chung
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

8.  Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.

Authors:  Shiv Gautam
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

9.  Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment.

Authors:  Byungsu Kim; Sangeok Kim; Roger S McIntyre; Hui Joon Park; Seong Yoon Kim; Yeon Ho Joo
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.